Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

Colin R. Simpson*, Steven Kerr, Srinivasa Vittal Katikireddi, Colin McCowan, Lewis D. Ritchie, Jiafeng Pan, Sarah J. Stock, Igor Rudan, Ruby S. M. Tsang, Simon de Lusignan, F. D. Richard Hobbs, Ashley Akbari, Ronan A. Lyons, Chris Robertson, Aziz Sheikh*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology